NCT05177640View on ClinicalTrials.gov

Biodistribution and Dosimetry of 99mTc-Duramycin

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 17, 2021

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

99mTc-Duramycin

This is a single dose study of 99mTc-duramycin in healthy volunteers who will undergo serial SPECT scanning

Trial Locations (1)

2650

University Hospital Antwerp, Edegem

Sponsors
All Listed Sponsors
collaborator

Molecular Targeting Technologies, Inc.

INDUSTRY

lead

University Hospital, Antwerp

OTHER

NCT05177640 - Biodistribution and Dosimetry of 99mTc-Duramycin | Biotech Hunter | Biotech Hunter